{"transactions":[{"id":671641,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-01T21:48:45.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":5.8644,"value":87966.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.80 to $5.9250 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":62065,"source":{"system":"sec-edgar","filing":"0001493152-26-041068","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226041068/ownership.xml","form_type":"4"}},{"id":764932,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T20:30:25.000Z","date":"2026-05-26","kind":"gift","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":77065,"source":{"system":"sec-edgar","filing":"0001493152-26-025258","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226025258/ownership.xml","form_type":"4"}},{"id":766977,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T21:24:26.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":6500,"price":5.4558,"value":35462.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.44 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":77565,"source":{"system":"sec-edgar","filing":"0001493152-26-025085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226025085/ownership.xml","form_type":"4"}},{"id":926174,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-02T21:30:01.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":5.0906,"value":10181.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":84065,"source":{"system":"sec-edgar","filing":"0001493152-26-004759","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226004759/ownership.xml","form_type":"4"}},{"id":930626,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-27T21:30:19.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":37313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on January 26, 2027."}],"balance_after":86065,"source":{"system":"sec-edgar","filing":"0001493152-26-003804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003804/ownership.xml","form_type":"4"}},{"id":934755,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T21:30:11.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":13500,"price":5.2277,"value":70573.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.21 to $5.235 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":48752,"source":{"system":"sec-edgar","filing":"0001493152-26-003094","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003094/ownership.xml","form_type":"4"}},{"id":999494,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:30:07.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":4.7445,"value":71167.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.885 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":62252,"source":{"system":"sec-edgar","filing":"0001493152-25-023532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225023532/ownership.xml","form_type":"4"}},{"id":1089815,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-10T20:30:28.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":13093,"price":5.8557,"value":76668.6801,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.92 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":77252,"source":{"system":"sec-edgar","filing":"0001641172-25-018599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225018599/ownership.xml","form_type":"4"}},{"id":1134351,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-27T23:57:08.000Z","date":"2025-05-27","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":6.38,"value":12760.0,"ownership":{"direct":true},"balance_after":90435,"source":{"system":"sec-edgar","filing":"0001641172-25-012556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225012556/ownership.xml","form_type":"4"}},{"id":1146464,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T21:23:52.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":8000,"price":5.68,"value":45440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $5.63 to $5.77 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":92435,"source":{"system":"sec-edgar","filing":"0001641172-25-011289","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225011289/ownership.xml","form_type":"4"}},{"id":1288473,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T01:37:35.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":36101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon vesting, a portion of the restricted stock may be surrendered to satisfy the reporting person's tax withholding obligation. Any deemed disposition of the withheld shares would be exempt pursuant to Rule 16b-3(e)."},{"field":"shares","element":"transactionShares","label":"F2","text":"All of the restricted stock will vest on January 31, 2026."}],"balance_after":100435,"source":{"system":"sec-edgar","filing":"0001493152-25-004749","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225004749/ownership.xml","form_type":"4"}},{"id":1290221,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-31T21:30:17.000Z","date":"2025-01-29","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":5.38,"value":21520.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $5.35 to $5.41 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":64334,"source":{"system":"sec-edgar","filing":"0001493152-25-004437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225004437/ownership.xml","form_type":"4"}},{"id":1299253,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-21T21:30:11.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":5.1,"value":20400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $5.08 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":68334,"source":{"system":"sec-edgar","filing":"0001493152-25-003052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225003052/ownership.xml","form_type":"4"}},{"id":1422644,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-27T23:06:06.000Z","date":"2024-08-26","kind":"grant","planned":false,"acquired":true,"shares":11797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The acquisition was exempt pursuant to Rule 16b-3(d)."},{"field":"shares","element":"transactionShares","label":"F2","text":"This stock grant represents the remainder of the 2024 annual grant to board of directors. This portion of the annual stock grant was withheld until all employees/management were allocated their shares and in order to enable onboarding of two new Board members. All of the restricted stock will vest on August 26, 2025."}],"balance_after":72334,"source":{"system":"sec-edgar","filing":"0001493152-24-034050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224034050/ownership.xml","form_type":"4"}},{"id":1458008,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-09T20:35:36.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":23611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on July 8, 2025."}],"balance_after":60537,"source":{"system":"sec-edgar","filing":"0001493152-24-026644","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026644/ownership.xml","form_type":"4"}},{"id":1473977,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T20:30:17.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":25890,"price":4.51,"value":116763.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $4.55 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":36926,"source":{"system":"sec-edgar","filing":"0001493152-24-024528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224024528/ownership.xml","form_type":"4"}},{"id":1674765,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-22T21:30:11.000Z","date":"2024-01-17","kind":"sale","planned":false,"acquired":false,"shares":7084,"price":5.11,"value":36199.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.15 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":62816,"source":{"system":"sec-edgar","filing":"0001493152-24-003193","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224003193/ownership.xml","form_type":"4"}},{"id":1771880,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T20:30:27.000Z","date":"2023-09-27","kind":"sale","planned":false,"acquired":false,"shares":6316,"price":3.9145,"value":24723.982,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8200 to $4.2050 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":69900,"source":{"system":"sec-edgar","filing":"0001493152-23-034856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223034856/ownership.xml","form_type":"4"}},{"id":1853512,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:05:32.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":58689,"price":4.62,"value":271143.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on June 14, 2024."}],"balance_after":76216,"source":{"system":"sec-edgar","filing":"0001493152-23-021652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223021652/ownership.xml","form_type":"4"}},{"id":1903613,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T20:05:36.000Z","date":"2023-04-25","kind":"sale","planned":false,"acquired":false,"shares":887,"price":3.25,"value":2882.75,"ownership":{"direct":true},"balance_after":17527,"source":{"system":"sec-edgar","filing":"0001493152-23-015587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223015587/ownership.xml","form_type":"4"}},{"id":2150194,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-28T20:33:11.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on September 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split."}],"balance_after":18414,"source":{"system":"sec-edgar","filing":"0001493152-22-027042","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222027042/ownership.xml","form_type":"4"}},{"id":2229055,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:17:40.000Z","date":"2022-06-15","kind":"sale","acquired":false,"shares":20000,"price":0.1549,"value":3098.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the average weighted price of sales on June 15, 2022. The shares were sold in multiple transactions at prices ranging from $0.152 to $0.157, inclusive. The reporting person undertakes to provide Abeona Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":27181,"source":{"system":"sec-edgar","filing":"0001493152-22-017168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222017168/ownership.xml","form_type":"4"}},{"id":2240936,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:05:46.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":35000,"price":0.1561,"value":5463.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the average weighted price of sales on June 6, 2022. The shares were sold in multiple transactions at prices ranging from $0.155 to $0.1617, inclusive. The reporting person undertakes to provide Abeona Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":47181,"source":{"system":"sec-edgar","filing":"0001493152-22-016079","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222016079/ownership.xml","form_type":"4"}},{"id":2694352,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T01:44:11.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":98168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options will vest on November 25, 2021."}],"balance_after":98168,"derivative":{"exercise_price":1.49,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":98168},"source":{"system":"sec-edgar","filing":"0001493152-21-013118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013118/ownership.xml","form_type":"4"}},{"id":2694351,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T01:44:11.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":77181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on November 25, 2021."}],"balance_after":82181,"source":{"system":"sec-edgar","filing":"0001493152-21-013118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013118/ownership.xml","form_type":"4"}},{"id":3514247,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-24T00:34:21.000Z","date":"2019-05-21","kind":"grant","acquired":true,"shares":19827,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19827,"derivative":{"exercise_price":7.42,"exercise_date":"2019-11-21","expiration_date":"2029-05-21","underlying":"Common stock","underlying_shares":19827},"source":{"system":"sec-edgar","filing":"0001144204-19-028043","document":"tv522351_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419028043/tv522351_4.xml","form_type":"4"}},{"id":4129547,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-12-18T22:14:17.000Z","date":"2017-12-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control."}],"balance_after":30000,"derivative":{"exercise_price":16,"exercise_date":"2018-06-14","expiration_date":"2027-12-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000318306-17-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830617000005/primary_doc.xml","form_type":"4"}},{"id":4521338,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":18188,"kind":"person","name":"Alvino Mark","position":1,"cik":"0001356828","reported_name":"Alvino Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2016-12-16T01:07:14.000Z","date":"2016-12-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control."}],"balance_after":50000,"derivative":{"exercise_price":4.45,"exercise_date":"2017-06-13","expiration_date":"2026-12-13","underlying":"Common stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000318306-16-000053","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830616000053/primary_doc.xml","form_type":"4"}}]}